Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Interrelationships between prostacyclin and thromboxane A2.

S Moncada, J R Vane

    Ciba Foundation Symposium
    |January 1, 1980
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The relationship between the penetration of tryptamine and 5-hydroxytryptamine into smooth muscle and the associated contractions.

    British journal of pharmacology and chemotherapy·2008
    Same author

    An analysis of the responses of the isolated portal vein of the rabbit to electrical stimulation and to drugs.

    British journal of pharmacology and chemotherapy·2008
    Same author

    Adventures and excursions in bioassay: the stepping stones to prostacylin.

    Bioscience reports·2005
    Same author

    The mechanism of action of aspirin.

    Thrombosis research·2003
    Same author

    My life and times with enzymes and mediators.

    Medical science monitor : international medical journal of experimental and clinical research·2001
    Same author

    The fight against rheumatism: from willow bark to COX-1 sparing drugs.

    Journal of physiology and pharmacology : an official journal of the Polish Physiological Society·2001
    Same journal

    Precision agriculture: spatial and temporal variability of environmental quality. General reflections.

    Ciba Foundation symposium·1997
    Same journal

    Uncertainty in hydrogeological modelling.

    Ciba Foundation symposium·1997
    Same journal

    Optimal mapping of site-specific multivariate soil properties.

    Ciba Foundation symposium·1997
    Same journal

    Modelling for precision weed management.

    Ciba Foundation symposium·1997
    Same journal

    GIS support for precision agriculture: problems and possibilities.

    Ciba Foundation symposium·1997
    Same journal

    Spatial sampling.

    Ciba Foundation symposium·1997
    See all related articles

    Prostacyclin, a vessel wall substance, inhibits platelet aggregation. Its balance with thromboxane A2 is crucial for vascular homeostasis and may influence pulmonary circulation.

    Area of Science:

    • Biochemistry
    • Physiology
    • Vascular Biology

    Background:

    • Prostacyclin is derived from arachidonic acid metabolism in mammalian vessel walls.
    • It acts as a potent vasodilator and inhibits platelet aggregation by increasing cyclic AMP in platelets.
    • The enzyme for prostacyclin synthesis is primarily in the vascular endothelium, and it functions as a circulating hormone from the pulmonary circulation.

    Purpose of the Study:

    • To propose that platelet aggregability in vivo is regulated by a prostacyclin mechanism.
    • To explore the opposing roles of prostacyclin and thromboxane A2 in vascular homeostasis.
    • To discuss the implications of this balance in thrombosis, atherosclerosis, and pulmonary circulation control.

    Main Methods:

    • Review of existing literature on prostacyclin and thromboxane A2 metabolism and function.

    Related Experiment Videos

  • Analysis of the enzymatic pathways involved in arachidonic acid metabolism in vessel walls and platelets.
  • Discussion of the physiological balance between vasodilator and vasoconstrictor substances.

    • Main Results:

    • Arachidonic acid metabolism yields prostacyclin (vasodilator, anti-aggregatory) in vessel walls and thromboxane A2 (vasoconstrictor, pro-aggregatory) in platelets.
    • A balance exists between these opposing substances, critical for platelet-vessel wall interaction.
    • This balance is proposed as a key regulator of in vivo platelet aggregability.

    Conclusions:

    • The interplay between prostacyclin and thromboxane A2 is vital for maintaining vascular homeostasis.
    • Dysregulation of this balance may contribute to the development of thrombosis and atherosclerosis.
    • The balance may also play a significant role in regulating pulmonary circulation.